Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial

Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial

Acute ischemic stroke is currently a major cause of disability despite improvement in recanalization therapies. Stem cells represent a promising innovative strategy focused on reduction of neurologic sequelae by enhancement of brain plasticity. We performed a phase IIa, randomized, double-blind, pla...

Full description

Bibliographic Details
Main Authors: Elena de Celis-Ruiz, Blanca Fuentes, María Alonso de Leciñana, María Gutiérrez-Fernández, Alberto M. Borobia, Raquel Gutiérrez-Zúñiga, Gerardo Ruiz-Ares, Laura Otero-Ortega, Fernando Laso-García, Mari Carmen Gómez-de Frutos, Exuperio Díez-Tejedor
Format: Article
Language:English
Published: SAGE Publishing 2022-03-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897221083863

Internet

https://doi.org/10.1177/09636897221083863

Similar Items